CEP192 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.304000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.161800E-01
Normal-vs-Stage2
3.397600E-01
Normal-vs-Stage3
2.211000E-01
Normal-vs-Stage4
1.480440E-01
Stage1-vs-Stage2
6.646400E-01
Stage1-vs-Stage3
1.521560E-01
Stage1-vs-Stage4
5.916200E-01
Stage2-vs-Stage3
1.204130E-03
Stage2-vs-Stage4
3.294600E-01
Stage3-vs-Stage4
4.768800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.324200E-01
Normal-vs-AfricanAmerican
3.368600E-01
Normal-vs-Asian
3.283400E-01
Caucasian-vs-AfricanAmerican
9.700200E-01
Caucasian-vs-Asian
8.467800E-01
AfricanAmerican-vs-Asian
9.305000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.208600E-01
Normal-vs-Female
3.442800E-01
Male-vs-Female
3.678600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.011600E-01
Normal-vs-Age(41-60Yrs)
3.761000E-01
Normal-vs-Age(61-80Yrs)
3.055800E-01
Normal-vs-Age(81-100Yrs)
3.770600E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.148600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.470400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.602000E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.551900E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.541400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.235400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.185600E-01
Normal-vs-Daily Drinker
3.174600E-01
Normal-vs-Weekly Drinker
2.945000E-01
Normal-vs-Occasional Drinker
3.390400E-01
Normal-vs-Social Drinker
3.935600E-01
Non Drinker-vs-Daily Drinker
9.406200E-01
Non Drinker-vs-Weekly Drinker
5.360800E-01
Non Drinker-vs-Occasional Drinker
7.639800E-01
Non Drinker-vs-Social Drinker
1.289750E-01
Daily Drinker-vs-Weekly Drinker
6.771400E-01
Daily Drinker-vs-Occasional Drinker
7.506600E-01
Daily Drinker-vs-Social Drinker
2.241400E-01
Weekly Drinker-vs-Occasional Drinker
4.976200E-01
Weekly Drinker-vs-Social Drinker
8.589900E-02
Occasional Drinker-vs-Social Drinker
4.260000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.108600E-01
Normal-vs-Grade 2
1.743820E-01
Normal-vs-Grade 3
1.600020E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.059400E-01
Grade 1-vs-Grade 3
6.991800E-01
Grade 1-vs-Grade 4
2.108600E-01
Grade 2-vs-Grade 3
1.860840E-01
Grade 2-vs-Grade 4
1.743820E-01
Grade 3-vs-Grade 4
1.600020E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
2.788400E-01
Normal-vs-NonDiabetic
3.364600E-01
Diabetic-vs-NonDiabetic
3.777600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.227400E-01
Normal-vs-NoPancreatitis
3.191200E-01
Pancreatitis-vs-NoPancreatitis
9.773000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.096400E-01
Normal-vs-N1
3.404200E-01
N0-vs-N1
2.656600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.945000E-01
Normal-vs-TP53-NonMutant
3.681400E-01
TP53-Mutant-vs-TP53-NonMutant
5.497400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
